These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 11044360)
1. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360 [TBL] [Abstract][Full Text] [Related]
2. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome. Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320 [TBL] [Abstract][Full Text] [Related]
5. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Ho PJ; Baxter RC Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044 [TBL] [Abstract][Full Text] [Related]
8. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer]. Jiang B; Liu DB; Zhang X; DU LL; Han CZ Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535 [TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358 [TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271 [TBL] [Abstract][Full Text] [Related]
11. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer. Han JY; Choi BG; Choi JY; Lee SY; Ju SY Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391 [TBL] [Abstract][Full Text] [Related]
13. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer]. Wang H; Wan YX; Zhang QK Ai Zheng; 2004 Jun; 23(6):710-4. PubMed ID: 15191678 [TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus. Acerini CL; Clayton KL; Hintz R; Baker B; Watts A; Holly JM; Dunger DB Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133 [TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer. Miyata Y; Sakai H; Hayashi T; Kanetake H Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585 [TBL] [Abstract][Full Text] [Related]
17. [The expressions and clinical significance of IGFBP-2, -3 in both serum and tumor tissues in patients with epithelial ovarian cancer]. Yan XJ; Tian Y; Wang C; Wang XL; Di JM; Cheng JX Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):639-43. PubMed ID: 19764562 [TBL] [Abstract][Full Text] [Related]
18. [Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors]. Mohnike K; Kluba U; Blum WF; Aumann V; Vorwerk P; Mittler U Klin Padiatr; 1995; 207(4):225-9. PubMed ID: 7564158 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factors and their binding proteins in children with IDDM. Wacharasindhu S; Srivuthana S; Aroonparkmongkol S J Med Assoc Thai; 2002 Jan; 85(1):41-52. PubMed ID: 12075719 [TBL] [Abstract][Full Text] [Related]